XML 17 R6.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements Of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (5,229,104) $ (1,010,612)
Adjustments to reconcile net loss to net cash used in operations:    
Depreciation, depletion and amortization 70,202 4,218
Equity compensation 211,122
Write off of application costs incurred on abandoned patent applications 283,927
Change in fair value of warrant liability 5,453
Amortization of operating lease ROU 12,230
Changes in operating assets and liabilities:    
Increase in accounts receivable (29,530)
Increase in government grant receivable (485,783)
Decrease in prepaid expenses 239,369 5,064
Decrease (increase) in other current assets 9,538 (50,000)
Increase in accounts payable and accrued expenses 765,264 311,317
Increase in accrued interest payable 98,630 98,630
(Decrease) increase in other payables (191,455) 269
Net cash used in operating activities (3,759,807) (1,121,444)
CASH FLOWS FROM INVESTING ACTIVITIES    
Payments related to patent application costs (94,283) (217,639)
Purchase of fixed assets (1,670,808)
Net cash used in investing activities (1,765,091) (217,639)
CASH FLOWS FROM FINANCING ACTIVITIES    
Capital contribution by former majority member of AGIG 500,000
Proceeds from note payable - related party 885,000
Repayment of note payable - related party (3,500,000) (200,000)
Proceeds from equity line of credit draw downs 2,569,097
Shares issued for cash consideration 19,998,199
Transaction fees paid for share issuance (1,610,000)  
Exercise of pre-funded warrants 1,801
Payment to settle disputed placement agent fees for prior year stock sales (400,000)
Net cash provided by financing activities 17,059,097 1,185,000
Effect of exchange rate changes 46,346 (12,154)
Net Change in Cash and Cash Equivalents 11,580,545 (166,237)
Cash, beginning of period 4,618,621 525,809
Cash, end of period 16,199,166 359,572
Interest paid 93,917
Tax paid
SUPPLEMENTAL NON-CASH INVESTING AND FINANCING ACTIVITIES    
Purchase of fixed assets funded by accounts payable and accruals 1,007,853
Options and restricted share awards for accrued equity compensation liability $ 736,563